921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION?

921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? have?

921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? has 0 citations in the OpenAlex counts ScholarIQ stores.

When was 921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? published?

921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? has 2009 year in the ScholarIQ index.

What is the open-access status of 921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION??

921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? has bronze oa status in the ScholarIQ index.

What is the DOI of 921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION??

The DOI for 921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? is on the source record.

What is the OpenAlex record for 921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION??

The OpenAlex for 921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION? is on the source record.